The Center for Biosimilars today published an article that concluded that there is a fearful risk of being diagnosed with IBD Crohn’s or Colitis for those currently being treated with Etanercept. Respectfully, I believe this study is incomplete and does not tell the full story. Though I don’t currently have access to the full study, just the Wiley Online Library Summary and the Center for Biosimilars article, until Lifestyle and Diet are factored into these studies I believe they do not tell the complete story. 20 years of clinical and cost outcomes from Integrative Medicine* have demonstrated the following results:
Read More
Accidental Fear or Valid reporting? Risk of New IBD Rises for Patients Treated With Etanercept
Abdominal Pain, alopecia, ankylosing spondylitis, Biologics, C-reactive protein (CRP), CalProctetin, Crohn's Disease, DIAGNOSTIC TESTING, Joel's Story, pemphigus, Pharmaceuticals, psoriasis, Recommended Resources, RESEARCH, Resources, Rheumatoid Arthritis, Stool Analysis, SYMPTOMS, TREATMENT, Ulcerative Colitis, and vitiligo.
